Moderna’s Announcement Was Great News — Just Not For The Reason You Think
Moderna’s press release announcing the initial success in its Phase I trials of a Covid-19 vaccine was one of the main reasons the Dow Jones Industrials shot up by nearly a thousand points on Monday.
Moderna, a Boston-based ex-unicorn that has successfully developed and marketed as many drugs as you have, turned itself from a $6 billion…